Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 481

1.

Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.

de Luis DA, Sagrado MG, Aller R, Conde R, Izaola O.

Nutrition. 2010 Nov-Dec;26(11-12):1130-3. doi: 10.1016/j.nut.2008.11.019. Epub 2009 Feb 10.

PMID:
19211226
2.

Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.

de Luis DA, Sagrado MG, Conde R, Aller R, Izaola O.

Nutrition. 2013 Nov-Dec;29(11-12):1300-3. doi: 10.1016/j.nut.2008.11.005. Epub 2009 Jan 8.

PMID:
19131213
3.

Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.

de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Romero E.

Nutrition. 2008 Jun;24(6):517-21. doi: 10.1016/j.nut.2008.01.052. Epub 2008 Mar 17.

PMID:
18343636
4.

Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure.

de Luis DA, Sagrado MG, Conde R, Aller R, Izaola O, Romero E.

Ann Nutr Metab. 2007;51(5):416-20. Epub 2007 Nov 20.

PMID:
18025813
5.

Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.

Agueda M, Lasa A, Simon E, Ares R, Larrarte E, Labayen I.

Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):208-14. doi: 10.1016/j.numecd.2010.06.010. Epub 2010 Oct 14.

PMID:
20951014
6.

[Visfatin in obese patients, relation with cardiovascular risk factors, a cross sectional study].

de Luis DA, Ballesteros M, Ruiz E, Muñoz C, Penacho A, Iglesias P, Guzmán AL, Abreu C, Maldonado A, Delgado M, Martín LS, Puigdevall V, Romero E, Sagrado MG, Izaola O, Conde R; Mar Cordero y Rocio Aller, Grupo de Nutrición, Sociedad Castellano Leonesa de Endocrinología, diabetes y nutrición..

Med Clin (Barc). 2011 Jul 23;137(5):199-203. doi: 10.1016/j.medcli.2010.09.033. Epub 2011 Feb 5. Spanish.

PMID:
21296365
7.

Evaluation of adipocytokines in obese children with insulin resistance.

Taşçilar ME, Cekmez F, Meral C, Pirgon O, Tanju IA, Canpolat FE, Abaci A, Tapan S, Eker I.

Turk J Pediatr. 2011 May-Jun;53(3):269-73.

PMID:
21980807
8.

Relation of phase angle tertiles with blood adipocytokines levels, insulin resistance and cardiovascular risk factors in obese women patients.

de Luis DA, Aller R, Romero E, Dueñas A, Perez Castrillon JL.

Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):521-6.

PMID:
20712259
9.

Adipokines and cytokines in non-alcoholic fatty liver disease.

Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM.

Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21. Epub 2007 Dec 10.

10.

High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients.

Labruna G, Pasanisi F, Nardelli C, Caso R, Vitale DF, Contaldo F, Sacchetti L.

Obesity (Silver Spring). 2011 Jul;19(7):1492-6. doi: 10.1038/oby.2010.309. Epub 2010 Dec 23.

11.

Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients.

de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Perez Castrillon JL, Dueñas A.

Diabetes Res Clin Pract. 2009 May;84(2):174-8. doi: 10.1016/j.diabres.2009.01.017. Epub 2009 Feb 24.

PMID:
19243851
12.

Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.

Spanos N, Tziomalos K, Macut D, Koiou E, Kandaraki EA, Delkos D, Tsourdi E, Panidis D.

Obes Facts. 2012;5(4):495-504. doi: 10.1159/000341579. Epub 2012 Jul 23.

13.

Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.

Martos-Moreno GÁ, Kratzsch J, Körner A, Barrios V, Hawkins F, Kiess W, Argente J.

Int J Obes (Lond). 2011 Oct;35(10):1355-62. doi: 10.1038/ijo.2010.280. Epub 2011 Jan 25.

PMID:
21266955
14.

Circulating adipocytokines in morbid obese patients, relation with cardiovascular risk factors and anthropometric parameters.

de Luis DA, González Sagrado M, Conde R, Aller R, Izaola O, Castro MJ.

Nutr Hosp. 2011 Jan-Feb;26(1):91-6.

15.

Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women.

Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C, Bambara V, Negri M, Bosello O, Zamboni M.

Am J Clin Nutr. 2006 Nov;84(5):1193-9.

16.

Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?

Vilarrasa N, Vendrell J, Maravall J, Elío I, Solano E, San José P, García I, Virgili N, Soler J, Gómez JM.

Endocrine. 2010 Oct;38(2):235-42. doi: 10.1007/s12020-010-9379-4. Epub 2010 Jul 23.

PMID:
21046484
17.

Adipose expression of adipocytokines in women with polycystic ovary syndrome.

Svendsen PF, Christiansen M, Hedley PL, Nilas L, Pedersen SB, Madsbad S.

Fertil Steril. 2012 Jul;98(1):235-41. doi: 10.1016/j.fertnstert.2012.03.056. Epub 2012 May 16.

PMID:
22607892
18.

Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.

de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, de la Fuente B, Perez Castrillon JL.

Eur Rev Med Pharmacol Sci. 2009 Nov-Dec;13(6):413-8.

PMID:
20085121
19.

Association of adipokines with obesity in children and adolescents.

Jaleel A, Aheed B, Jaleel S, Majeed R, Zuberi A, Khan S, Ahmed B, Shoukat F, Hashim H.

Biomark Med. 2013 Oct;7(5):731-5. doi: 10.2217/bmm.13.41.

PMID:
24044565
20.

Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.

Wang P, Bai C, Xu QY, Xu TY, Su DF, Sassard J, Miao CY.

Clin Exp Pharmacol Physiol. 2010 Sep;37(9):894-9. doi: 10.1111/j.1440-1681.2010.05402.x. Epub 2010 Apr 26.

PMID:
20456420

Supplemental Content

Support Center